Anna Wuolikainen

Small striatal huntingtin inclusions in patients with motor neuron disease with reduced penetrance and intermediate HTT gene expansions.

Journal: Human molecular genetics

Published: May 22, 2024

Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics.

Journal: Scientific reports

Published: May 21, 2021

Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: October 11, 2019

Targeted Multiple Reaction Monitoring Analysis of CSF Identifies UCHL1 and GPNMB as Candidate Biomarkers for ALS.

Journal: Journal of molecular neuroscience : MN

Published: October 25, 2018

Long-term stability of the alcohol consumption biomarker phosphatidylethanol in erythrocytes at -80 °C.

Journal: Clinical mass spectrometry (Del Mar, Calif.)

Published: June 18, 2018

Sequence variations in C9orf72 downstream of the hexanucleotide repeat region and its effect on repeat-primed PCR interpretation: a large multinational screening study.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: December 13, 2016

A 50 bp deletion in the SOD1 promoter lowers enzyme expression but is not associated with ALS in Sweden.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: March 23, 2016

Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects.

Journal: Molecular bioSystems

Published: February 18, 2016

Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples.

Journal: Metabolomics : Official journal of the Metabolomic Society

Published: January 08, 2015

Extensive size variability of the GGGGCC expansion in C9orf72 in both neuronal and non-neuronal tissues in 18 patients with ALS or FTD.

Journal: Human molecular genetics

Published: December 11, 2014

Cholesterol, oxysterol, triglyceride, and coenzyme Q homeostasis in ALS. Evidence against the hypothesis that elevated 27-hydroxycholesterol is a pathogenic factor.

Journal: PloS one

Published: August 07, 2014

Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson's disease.

Journal: Journal of Parkinson's disease

Published: June 15, 2014

Small striatal huntingtin inclusions in patients with motor neuron disease with reduced penetrance and intermediate HTT gene expansions.

Small striatal huntingtin inclusions in patients with motor neuron disease with reduced penetrance and intermediate HTT gene expansions.

Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics.

Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics.

Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis.

Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis.

Targeted Multiple Reaction Monitoring Analysis of CSF Identifies UCHL1 and GPNMB as Candidate Biomarkers for ALS.

Targeted Multiple Reaction Monitoring Analysis of CSF Identifies UCHL1 and GPNMB as Candidate Biomarkers for ALS.

Long-term stability of the alcohol consumption biomarker phosphatidylethanol in erythrocytes at -80 °C.

Long-term stability of the alcohol consumption biomarker phosphatidylethanol in erythrocytes at -80 °C.

Sequence variations in C9orf72 downstream of the hexanucleotide repeat region and its effect on repeat-primed PCR interpretation: a large multinational screening study.

Sequence variations in C9orf72 downstream of the hexanucleotide repeat region and its effect on repeat-primed PCR interpretation: a large multinational screening study.

A 50 bp deletion in the SOD1 promoter lowers enzyme expression but is not associated with ALS in Sweden.

A 50 bp deletion in the SOD1 promoter lowers enzyme expression but is not associated with ALS in Sweden.

Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects.

Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects.

Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples.

Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples.

Extensive size variability of the GGGGCC expansion in C9orf72 in both neuronal and non-neuronal tissues in 18 patients with ALS or FTD.

Extensive size variability of the GGGGCC expansion in C9orf72 in both neuronal and non-neuronal tissues in 18 patients with ALS or FTD.

Cholesterol, oxysterol, triglyceride, and coenzyme Q homeostasis in ALS. Evidence against the hypothesis that elevated 27-hydroxycholesterol is a pathogenic factor.

Cholesterol, oxysterol, triglyceride, and coenzyme Q homeostasis in ALS. Evidence against the hypothesis that elevated 27-hydroxycholesterol is a pathogenic factor.

Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson's disease.

Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson's disease.

Long-term stability of the alcohol consumption biomarker phosphatidylethanol in erythrocytes at -80 °C.

Long-term stability of the alcohol consumption biomarker phosphatidylethanol in erythrocytes at -80 °C.